SCHEMBL13452971

SCHEMBL13452971

CC(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYSLTR1 Q9Y271 11/20 0.81
▸ CYSLTR2 Q9NS75 10/20 0.80
▸ CYP2C8 P10632 2/20 0.80
▸ MEN1 O00255 1/20 0.80
▸ RECQL P46063 1/20 0.80
▸ BLM P54132 1/20 0.80
▸ KMT2A Q03164 1/20 0.80
▸ ABCB11 O95342 1/20 0.80
▸ EGFR P00533 1/20 0.80
▸ ESR1 P03372 1/20 0.80
▸ NR3C1 P04150 1/20 0.80
▸ FYN P06241 1/20 0.80
▸ PGR P06401 1/20 0.80
▸ ADRB2 P07550 1/20 0.80
▸ ADRB1 P08588 1/20 0.80
▸ ADRA2A P08913 1/20 0.80
▸ ADORA3 P0DMS8 1/20 0.80
▸ CHRM1 P11229 1/20 0.80
▸ ADRB3 P13945 1/20 0.80
▸ ADRA2B P18089 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21888230 0.95 CYSLTR1 (0.82) CYSLTR1CYSLTR2CYP2C8MEN1RECQL
SCHEMBL21888231 0.95 CYSLTR1 (0.82) CYSLTR1CYSLTR2CYP2C8MEN1RECQL
SCHEMBL4776149 0.93 CYSLTR1 (0.79) CYSLTR1CYSLTR2CYP2C8MEN1RECQL
SCHEMBL2882902 0.93 CYSLTR1 (0.79) CYSLTR1CYSLTR2CYP2C8MEN1RECQL
SCHEMBL2877768 0.93 CYSLTR1 (0.79) CYSLTR1CYSLTR2CYP2C8MEN1RECQL
SCHEMBL4742853 0.93 CYSLTR1 (0.79) CYSLTR1CYSLTR2CYP2C8MEN1RECQL
SCHEMBL5073495 0.93 CYSLTR1 (0.79) CYSLTR1CYSLTR2CYP2C8MEN1RECQL
SCHEMBL3037426 0.93 CYSLTR1 (0.79) CYSLTR1CYSLTR2CYP2C8MEN1RECQL
SCHEMBL3041868 0.93 CYSLTR1 (0.79) CYSLTR1CYSLTR2CYP2C8MEN1RECQL
SCHEMBL5315207 0.93 CYSLTR1 (0.78) CYSLTR1CYSLTR2CYP2C8MEN1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740545-B1 PROCESS FOR MAKING MONTELUKAST AND INTERMEDIATES THEREFOR SYNTHON BV (NL) 2010-03-24 — — EP disclosed
WO-2009048236-A1 METHOD FOR THE PREPARATION OF MONTELUKAST ACID IN IONIC LIQUID MEDIUM HANMI PHARM. CO., LTD. (KR) 2009-04-16 — — WO disclosed
Send feedback